Immunohistochemistry of colorectal carcinoma: Current practice and evolving applications

Human Pathology

Volumn 44, Issue 2, 2013, Pages 151-163

  Taliano, Ross James ^a   Legolvan, Mark ^a   Resnick, Murray B ^a  

^a RHODE ISLAND HOSPITAL   (United States)

Author keywords

Colon; Immunohistochemistry; Rectum

Indexed keywords

BETA CATENIN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN; DESMIN; TRANSCRIPTION FACTOR CDX2; VILLIN; VIMENTIN;

ARTICLE; CANCER PROGNOSIS; CLINICAL FEATURE; CLINICAL PRACTICE; COLON ADENOCARCINOMA; COLORECTAL CARCINOMA; ENDOMETRIUM CARCINOMA; EPITHELIUM CELL; EXERCISE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; MOLECULAR PATHOLOGY; NEUROFILAMENT; OVARY CARCINOMA; PATHOLOGIST; PROTEIN EXPRESSION; RECTUM CARCINOMA; SIGNET RING CARCINOMA; URACHUS;

ADENOCARCINOMA; COLON; COLORECTAL NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSATELLITE INSTABILITY; RECTUM; TUMOR MARKERS, BIOLOGICAL;

EID: 84872687458     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.04.017     Document Type: Article

References (139)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2011 69 90
2. R. Moll, W.W. Franke, D.L. Schiller, B. Geiger, and R. Krepler The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells Cell 31 1982 11 24 (Pubitemid 13215192)
3. P. Chu, E. Wu, and L.M. Weiss Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases Mod Pathol 13 2000 962 972
4. C.C.A.P. Wauters, F. Smedts, L.G.M. Gerrits, F.T. Bosman, and F. Ramaekers Keratins 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary Hum Pathol 26 1995 852 855
5. R. Vang, A.M. Gown, and T.S. Barry Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases Am J Surg Pathol 30 2006 1130 1139 (Pubitemid 44299346)
6. M. Sarbia, F. Fritze, H. Geddert, C. von Weyhern, R. Rosenberg, and K. Gellert Differentiation between pancreaticobiliary and upper gastrointestinal adenocarcinomas: is analysis of cytokeratin 17 expression helpful? Am J Clin Pathol 128 2007 255 259 (Pubitemid 47262623)
7. M. Miettinen, M.P. Nobel, B.T. Tuma, and A.J. Kovatich Keratin 17: immunohistochemical mapping of its distribution in human epithelial tumors and its potential applications Appl Immunohistochem 5 1997 152 159
8. N.S. Goldstein, A. Long, S.F. Kuan, and J. Hart Colon signet ring cell adenocarcinoma: immunohistochemical characterization and comparison with gastric and typical colon adenocarcinomas Appl Immunohistochem Mol Morphol 8 2000 183 188
9. D.G. Silberg, G.P. Swain, E.R. Suh, and P.G. Traber Cdx1 and Cdx2 expression during intestinal development Gastroenterology 119 2000 961 971
10. C.A. Moskaluk, H. Zhang, S.M. Powell, L.A. Cerilli, G.M. Hampton, and H.F. Frierson Cdx2 protein expression in normal and malignant human tissues: an immunohistochemical survey using tissue microarrays Mod Pathol 16 2003 913 919 (Pubitemid 37152021)
11. R.W. Werling, H. Yaziji, C.E. Bacchi, and A.M. Gown CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas Am J Surg Pathol 27 2003 303 310 (Pubitemid 36245795)
12. R. Vang, A.M. Gown, and L.S. Wu Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7 Mod Pathol 19 2006 1421 1428 (Pubitemid 44624160)
13. A. Bretscher, and K. Weber Villin: the major microfilament-associated protein of the intestinal microvillus Proc Natl Acad Sci U S A 76 1979 2321 2325 (Pubitemid 9184921)
14. S. Robine, C. Huet, and R. Moll Can villin be used to identify malignant and undifferentiated normal digestive epithelial cells? Proc Natl Acad Sci U S A 82 1985 8488 8492 (Pubitemid 16105086)
15. R. Moll, S. Robine, B. Dudouet, and D. Louvard Villin: a cytoskeletal protein and a differentiation marker expressed in some human adenocarcinomas Virchows Archiv B Cell Pathol 54 1987 155 169 (Pubitemid 17164663)
16. C.E. Bacchi, and A.M. Gown Distribution and pattern of expression of villin, a gastrointestinal-associated cytoskeletal protein, in human carcinomas: a study employing paraffin-embedded tissue Lab Invest 64 1991 418 424
17. K. Willert, and R. Nusse β-Catenin: a key mediator of Wnt signaling Curr Opin Genet Dev 8 1998 95 102 (Pubitemid 28122147)
18. H. Clevers Wnt/β-catenin signaling in development and disease Cell 127 2006 469 480
19. S. Hammarström The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues Semin Cancer Biol 9 1999 67 81 (Pubitemid 29265523)
20. S.K. Lau, S. Prakash, S.A. Geller, and R. Alsabeh Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma Hum Pathol 33 2002 1175 1181 (Pubitemid 36020066)
21. K. Sheahan, M.J. O'Brien, and B. Burke Differential reactivities of carcinoembryonic antigen (CEA) and CEA-related monoclonal and polyclonal antibodies in common epithelial malignancies Am J Clin Pathol 94 1990 157 164 (Pubitemid 20229562)
22. L. Amery, M. Fransen, K. De Nys, G.P. Mannaerts, and P.P. Van Veldhoven Mitochondrial and peroxisomal targeting of 2-methylacyl-CoA racemase in humans J Lipid Res 41 2000 1752 1759
23. S. Ferdinandusse, S. Denis, L. IJlst, G. Dacremont, H.R. Waterham, and R.J. Wanders Subcellular localization and physiological role of alpha-methylacyl-CoA racemase J Lipid Res 41 2000 1890 1896
24. Z. Jiang, G.R. Fanger, and B.A. Woda Expression of alpha-methylacyl-CoA racemase (P504s) in various malignant neoplasms and normal tissues: a study of 761 cases Hum Pathol 34 2003 792 796 (Pubitemid 37040616)
25. M. Zhou, A.M. Chinnaiyan, C.G. Kleer, P.C. Lucas, and M.A. Rubin Alpha-methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions Am J Surg Pathol 26 2002 926 931 (Pubitemid 34747646)
26. R. Kuefer, S. Varambally, and M. Zhou Alpha-methylacyl-CoA racemase: expression levels of this novel cancer biomarker depend on tumor differentiation Am J Pathol 161 2002 841 848 (Pubitemid 34988371)
27. J.F. Forstner, and G.G. Forstner Gastrointestinal mucus L.R. Johnson, Physiology of the gastrointestinal tract 1994 Raven New York 1255 1283
28. W.J. Lennarz Mucin family of glycoproteins W.J. Lennarz, Encyclopedia of biological chemistry 2004 Elsevier Amsterdam 758 764
29. Y. Cao, P.M. Schlag, and U. Karsten Immunodetection of epithelial mucin (MUC1, MUC3) and mucin-associated glycotopes (TF, Tn, and sialosyl-Tn) in benign and malignant lesions of colonic epithelium: a polar localization corresponds to malignant transformation Virchows Arch 431 1997 159 166 (Pubitemid 27440359)
30. J.C. Byrd, and R.S. Bresalier Mucins and mucin binding proteins in colorectal cancer Cancer Metastasis Rev 23 2004 77 99 (Pubitemid 38221597)
31. D.M. Swallow, S. Gendler, and B. Griffiths The hypervariable gene locus PUM, which codes for the tumour associated epithelial mucins, is located on chromosome 1, within the region 1q21-24 Ann Hum Genet 51 1987 289 294
32. C. Hanski, M. Hofmeier, and A. Schmitt-Gräff Overexpression or ectopic expression of MUC2 is the common property of mucinous carcinomas of the colon, pancreas, breast, and ovary J Pathol 182 1997 385 391 (Pubitemid 27317202)
33. K. Ookawa, T. Kudo, S. Aizawa, H. Saito, and S. Tsuchida Transcriptional activation of the MUC2 gene by p53 J Biol Chem 277 2002 48270 48275 (Pubitemid 35470779)
34. S.Y. Park, H.S. Lee, G. Choe, J.H. Chung, and W.H. Kim Clinicopathological characteristics, microsatellite instability, and expression of mucin core proteins and p53 in colorectal mucinous adenocarcinomas in relation to location Virchows Arch 449 2006 40 47 (Pubitemid 43988364)
35. R.O. Perez, B.H. Bresciani, and C. Bresciani Mucinous colorectal adenocarcinoma: influence of mucin expression (Muc1, 2 and 5) on clinico-pathological features and prognosis Int J Colorectal Dis 23 2008 757 765
36. H. Kang, B.S. Min, and K.Y. Lee Loss of E-cadherin and MUC2 expressions correlated with poor survival in patients with stages II and III colorectal carcinoma Ann Surg Oncol 18 2011 711 719
37. A. Lugli, I. Zlobec, and P. Minoo Prognostic significance of the wnt signalling pathway molecules APC, β-catenin and E-cadherin in colorectal cancer: a tissue microarray-based analysis Histopathology 50 2007 453 464 (Pubitemid 46328181)
38. S.C. Glasgow, J. Yu, L.P. Carvalho, W.D. Shannon, J.W. Fleshman, and H.L. McLeod Unfavourable expression of pharmacologic markers in mucinous colorectal cancer Br J Cancer 92 2005 259 264 (Pubitemid 40343138)
39. Y. Ajioka, L.J. Allison, and J.R. Jass Significance of MUC1 and MUC2 mucin expression in colorectal cancer J Clin Pathol 49 1996 560 564 (Pubitemid 26232730)
40. K. Matsuda, T. Masaki, and T. Watanabe Clinical significance of MUC1 and MUC2 mucin and p53 protein expression in colorectal carcinoma Jap J Clin Path 30 2000 89 94
41. S.E. Baldus, S.P. Mönig, and F. Hanisch Comparative evaluation of the prognostic value of MUC1, MUC2, sialyl-Lewisa and sialyl-Lewisx antigens in colorectal adenocarcinoma Histopathology 40 2002 440 449 (Pubitemid 34535444)
42. C. Shanmugam, N.C. Jhala, and V.R. Katkoori Prognostic value of mucin 4 expression in colorectal adenocarcinomas Cancer 116 2010 3577 3586
43. S. Nakamori, D.M. Ota, K.R. Cleary, K. Shirotani, and T. Irimura MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma Gastroenterology 106 1994 353 361 (Pubitemid 24041211)
44. A.E. Bartman, S.J. Sanderson, and S.L. Ewing Aberrant expression of MUC5AC and MUC6 gastric mucin genes in colorectal polyps Int J Cancer 80 1999 210 218 (Pubitemid 29001724)
45. A.E. Biemer-Hüttmann, M.D. Walsh, and M.A. McGuckin Immunohistochemical staining patterns of MUC1, MUC2, MUC4, and MUC5AC mucins in hyperplastic polyps, serrated adenomas, and traditional adenomas of the colorectum J Histochem Cytochem 47 1999 1039 1047 (Pubitemid 29379903)
46. S.R. Owens, S.I. Chiosea, and S.F. Kuan Selective expression of gastric mucin MUC6 in colonic sessile serrated adenoma but not in hyperplastic polyp aids in morphological diagnosis of serrated polyps Mod Pathol 21 2008 660 669 (Pubitemid 351744844)
47. A. Vincent, M. Perrais, J.L. Desseyn, J.P. Aubert, P. Pigny, and I. Van Seuningen Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells Oncogene 26 2007 6566 6576 (Pubitemid 47530602)
48. C.R. Boland, and A. Goel Microsatellite instability in colorectal cancer Gastroenterology 138 2010 2073 2087
49. LeGolvan M, Taliano R, Resnick MB. Molecular diagnostic applications in the diagnosis and management of colorectal cancer: a practical approach. Hum Pathol In Press.
50. J.K. Greenson, S.C. Huang, and C. Herron Pathologic predictors of microsatellite instability in colorectal cancer Am J Surg Pathol 33 2009 126 133
51. Y.Y. Chou, Y.M. Jeng, H.L. Kao, T. Chen, T.L. Mao, and M.C. Lin Differentiation of ovarian mucinous carcinoma and metastatic colorectal adenocarcinoma by immunostaining with β-catenin Histopathology 43 2003 151 156 (Pubitemid 36963159)
52. J.L. Dennis, T.R. Hvidsten, and E.C. Wit Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm Clin Cancer Res 11 2005 3766 3772 (Pubitemid 40685594)
53. S. Logani, E. Oliva, P.M. Arnell, M.B. Amin, and R.H. Young Use of novel immunohistochemical markers expressed in colonic adenocarcinoma to distinguish primary ovarian tumors from metastatic colorectal carcinoma Mod Pathol 18 2005 19 25 (Pubitemid 40128090)
54. P.A. Sylvester, N. Myerscough, and B.F. Warren Differential expression of the chromosome 11 mucin genes in colorectal cancer J Pathol 195 2001 327 335
55. P.J. Zhang, M. Shah, G.W. Spiegel, and J.J. Brooks Cytokeratin 7 immunoreactivity in rectal adenocarcinomas Appl Immunohistochem Mol Morphol 11 2003 306 310 (Pubitemid 37522680)
56. R.S. Saad, J.F. Silverman, M.A. Khalifa, and C. Rowsell CDX2, cytokeratins 7 and 20 immunoreactivity in rectal adenocarcinoma Appl Immunohistochem Mol Morphol 17 2009 196 201
57. A. Lugli, A. Tzankov, I. Zlobec, and L.M. Terracciano Differential diagnostic and functional role of the multi-marker phenotype CDX2/CK20/CK7 in colorectal cancer stratified by mismatch repair status Mod Pathol 21 2008 1403 1412
58. D.K. McGregor, T.T. Wu, A. Rashid, R. Luthra, and S.R. Hamilton Reduced expression of cytokeratin 20 in colorectal carcinomas with high levels of microsatellite instability Am J Surg Pathol 28 2004 712 718 (Pubitemid 38685885)
59. B. Winn, R. Tavares, and J. Fanion Differentiating the undifferentiated: immunohistochemical profile of medullary carcinoma of the colon with an emphasis on intestinal differentiation Hum Pathol 40 2009 398 404
60. T. Hinoi, M. Tani, and P.C. Lucas Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon Am J Pathol 159 2001 2239 2248 (Pubitemid 33104277)
61. R. Salovaara, S. Roth, and A. Loukola Frequent loss of SMAD4/DPC4 protein in colorectal cancers Gut 51 2002 56 59 (Pubitemid 34717744)
62. P.G. Chu, and L.M. Weiss Immunohistochemical characterization of signet-ring cell carcinomas of the stomach, breast, and colon Am J Clin Pathol 121 2004 884 892 (Pubitemid 38669284)
63. M.D. Nguyen, B. Plasil, P. Wen, and W.L. Frankel Mucin profiles in signet-ring cell carcinoma Arch Pathol Lab Med 130 2006 799 804 (Pubitemid 43886998)
64. Y. Baba, K. Nosho, and K. Shima Relationship of CDX2 loss with molecular features and prognosis in colorectal cancer Clin Cancer Res 15 2009 4665 4673
65. Y. Kawabata, N. Tomita, and T. Monden Molecular characteristics of poorly differentiated adenocarcinoma and signet-ring-cell carcinoma of colorectum Int J Cancer 84 1999 33 38 (Pubitemid 29059105)
66. S. Ogino, M. Brahmandam, T. Kawasaki, G.J. Kirkner, M. Loda, and C.S. Fuchs Combined analysis of COX-2 and p53 expressions reveals synergistic inverse correlations with microsatellite instability and CpG island methylator phenotype in colorectal cancer Neoplasia 8 2006 458 464 (Pubitemid 44035329)
67. H. Nassar Carcinomas with micropapillary morphology: clinical significance and current concepts Adv Anat Pathol 11 2004 297 303
68. K. Sakamoto, M. Watanabe, and C. De La Cruz Primary invasive micropapillary carcinoma of the colon Histopathology 47 2005 479 484 (Pubitemid 41626725)
69. P. Wen, Y. Xu, W.L. Frankel, and R. Shen Invasive micropapillary carcinoma of the sigmoid colon: distinct morphology and aggressive behavior Int J Clin Exp Pathol 1 2008 457 460
70. A.E. Smith Sehdev, P.S. Sehdev, and R.J. Kurman Noninvasive and invasive micropapillary (low-grade) serous carcinoma of the ovary: a clinicopathologic analysis of 135 cases Am J Surg Pathol 27 2003 725 736 (Pubitemid 36617509)
71. N. Kuroda, N. Tanida, and M. Ohara Anal canal adenocarcinoma with MUC5AC expression suggestive of anal gland origin Med Mol Morphol 40 2007 50 53 (Pubitemid 46475020)
72. R.H. Young From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary: part I. Historical perspective, general principles, mucinous tumors including the Krukenberg tumor Adv Anat Pathol 13 2006 205 227 (Pubitemid 44439976)
73. N.S. Goldstein, and M. Thomas Mucinous and nonmucinous bronchioloalveolar adenocarcinomas have distinct staining patterns with thyroid transcription factor and cytokeratin 20 antibodies Am J Clin Pathol 116 2001 319 325 (Pubitemid 32851962)
74. X.D. Bu, N. Li, and X.Q. Tian Altered expression of MUC2 and MUC5AC in progression of colorectal carcinoma World J Gastroenterol 16 2010 4089 4094
75. H. Ji, C. Isacson, J.D. Seidman, R.J. Kurman, and B.M. Ronnett Cytokeratins 7 and 20, Dpc4, and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors: Dpc4 assists in identifying metastatic pancreatic carcinomas Int J Gynecol Pathol 21 2002 391 400
76. A. Noske, A.K. Zimmermann, and R. Caduff Alpha-methylacyl-CoA racemase (AMACR) expression in epithelial ovarian cancer Virchows Arch 459 2011 91 97
77. W. Kildal, B. Risberg, and V.M. Abeler β-Catenin expression, DNA ploidy and clinicopathological features in ovarian cancer: a study in 253 patients Eur J Cancer 41 2005 1127 1134 (Pubitemid 40725570)
78. D. Tacha, D. Zhou, and L. Cheng Expression of PAX8 in normal and neoplastic tissues: a comprehensive immunohistochemical study Appl Immunohistochem Mol Morphol 19 2011 293 299
79. A.R. Laury, R. Perets, and H. Piao A comprehensive analysis of PAX8 expression in human epithelial tumors Am J Surg Pathol 35 2011 816 826
80. R. Vang, A.M. Gown, T.S. Barry, D.T. Wheeler, and B.M. Ronnett Immunohistochemistry for estrogen and progesterone receptors in the distinction of primary and metastatic mucinous tumors in the ovary: an analysis of 124 cases Mod Pathol 19 2006 97 105 (Pubitemid 43250984)
81. A. Dionigi, C. Facco, M.G. Tibiletti, B. Bernasconi, C. Riva, and C. Capella Ovarian metastases from colorectal carcinoma. Clinicopathologic profile, immunophenotype, and karyotype analysis Am J Clin Pathol 114 2000 111 122 (Pubitemid 34453192)
82. D.J. Dabbs, K. Sturtz, and R.J. Zaino The immunohistochemical discrimination of endometrioid adenocarcinomas Hum Pathol 27 1996 172 177 (Pubitemid 26049471)
83. D. Sarrió, G. Moreno-Bueno, and C. Sánchez-Estévez Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas Hum Pathol 37 2006 1042 1049 (Pubitemid 44080810)
84. C. Gamallo, J. Palacios, G. Moreno, Calvo de Mora J., Suárez A., and Armas A. β-catenin expression pattern in stage I and II ovarian carcinomas: relationship with {beta}-catenin gene mutations, clinicopathological features, and clinical outcome Am J Pathol 155 1999 527 536 (Pubitemid 29370402)
85. D.G. Rosen, Z. Zhang, B. Chang, X. Wang, E. Lin, and J. Liu Low membranous expression of β-catenin and high mitotic count predict poor prognosis in endometrioid carcinoma of the ovary Mod Pathol 23 2010 113 122
86. L. Tornillo CDX-2 immunostaining in primary and secondary ovarian carcinomas J Clin Pathol 57 2004 641 643
87. G.M. Groisman, A. Meir, and E. Sabo The value of Cdx2 immunostaining in differentiating primary ovarian carcinomas from colonic carcinomas metastatic to the ovaries Int J Gynecol Pathol 23 2004 52 57 (Pubitemid 38018238)
88. O. Houghton, L.E. Connolly, and W.G. McCluggage Morules in endometrioid proliferations of the uterus and ovary consistently express the intestinal transcription factor CDX2 Histopathology 53 2008 156 165 (Pubitemid 352032773)
89. J.H. Lagendijk, H. Mullink, P.J. Van Diest, G.A. Meijer, and C.J. Meijer Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites Hum Pathol 29 1998 491 497 (Pubitemid 28213469)
90. S.Y. Park, B.H. Kim, J.H. Kim, S. Lee, and G.H. Kang Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma Arch Pathol Lab Med 131 2007 1561 1567 (Pubitemid 47606722)
91. D.H. Castrillon, K.R. Lee, and M.R. Nucci Distinction between endometrial and endocervical adenocarcinoma: an immunohistochemical study Int J Gynecol Pathol 21 2002 4 10 (Pubitemid 34008346)
92. K.J. Park, M.P. Bramlage, L.H. Ellenson, and E.C. Pirog Immunoprofile of adenocarcinomas of the endometrium, endocervix, and ovary with mucinous differentiation Appl Immunohistochem Mol Morphol 17 2009 8 11
93. R. Torenbeek, J.H. Lagendijk, P.J. Van Diest, H. Bril, F.J. van de Molengraft, and C.J. Meijer Value of a panel of antibodies to identify the primary origin of adenocarcinomas presenting as bladder carcinoma Histopathology 32 1998 20 27
94. A. Nassar, M.B. Amin, D.G. Sexton, and C. Cohen Utility of alpha-methylacyl coenzyme A racemase (p504s antibody) as a diagnostic immunohistochemical marker for cancer Appl Immunohistochem Mol Morphol 13 2005 252 255 (Pubitemid 41209019)
95. A. Handra-Luca, S.M. Hong, K. Walter, C. Wolfgang, R. Hruban, and M. Goggins Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas Br J Cancer 104 2011 1296 1302
96. Y. Fuyuhiro, M. Yashiro, and S. Noda Clinical significance of vimentin-positive gastric cancer cells Anticancer Res 30 2010 5239 5243
97. M. Reid-Nicholson, P. Iyengar, A.J. Hummer, I. Linkov, M. Asher, and R.A. Soslow Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis Mod Pathol 19 2006 1091 1100 (Pubitemid 44106724)
98. M.L. Slattery, W.S. Samowitz, and J.A. Holden Estrogen and progesterone receptors in colon tumors Am J Clin Pathol 113 2000 364 368 (Pubitemid 30217383)
99. I.G. Kaklamanos, O.F. Bathe, and D. Franceschi Expression of receptors for estrogen and progesterone in malignant colonic mucosa as a prognostic factor for patient survival J Surg Oncol 72 1999 225 229 (Pubitemid 30007792)
100. M. Saegusa, and I. Okayasu Frequent nuclear β-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation J Pathol 194 2001 59 67
101. D.J. Grignon, J.Y. Ro, A.G. Ayala, D.E. Johnson, and N.G. Ordóñez Primary adenocarcinoma of the urinary bladder. A clinicopathologic analysis of 72 cases Cancer 67 1991 2165 2172
102. A. Gopalan, D.S. Sharp, and S.W. Fine Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation Am J Surg Pathol 33 2009 659 668
103. G.P. Paner, J.K. McKenney, and G.A. Barkan Immunohistochemical analysis in a morphologic spectrum of urachal epithelial neoplasms: diagnostic implications and pitfalls Am J Surg Pathol 35 2011 787 798
104. J. Jiang, T.M. Ulbright, and C. Younger Cytokeratin 7 and cytokeratin 20 in primary urinary bladder carcinoma and matched lymph node metastasis Arch Pathol Lab Med 125 2001 921 923 (Pubitemid 32623190)
105. M.R. Raspollini, G. Nesi, G. Baroni, L.R. Girardi, and G.L. Taddei Immunohistochemistry in the differential diagnosis between primary and secondary intestinal adenocarcinoma of the urinary bladder Appl Immunohistochem Mol Morphol 13 2005 358 362 (Pubitemid 41697399)
106. H.L. Wang, D.W. Lu, and L.M. Yerian Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma Am J Surg Pathol 25 2001 1380 1387 (Pubitemid 33022053)
107. N. Suh, X.J. Yang, M.S. Tretiakova, P.A. Humphrey, and H.L. Wang Value of CDX2, villin, and alpha-methylacyl coenzyme A racemase immunostains in the distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma Mod Pathol 18 2005 1217 1222 (Pubitemid 43079921)
108. P. Tamboli, S.K. Mohsin, S. Hailemariam, and M.B. Amin Colonic adenocarcinoma metastatic to the urinary tract versus primary tumors of the urinary tract with glandular differentiation: a report of 7 cases and investigation using a limited immunohistochemical panel Arch Pathol Lab Med 126 2002 1057 1063 (Pubitemid 36221843)
109. D.C. Parker, A.L. Folpe, and J. Bell Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas Am J Surg Pathol 27 2003 1 10 (Pubitemid 36014893)
110. M.S. Tsao, and R.S. Fraser Primary pulmonary adenocarcinoma with enteric differentiation Cancer 68 1991 1754 1757
111. S.A. Yousem Pulmonary intestinal-type adenocarcinoma does not show enteric differentiation by immunohistochemical study Mod Pathol 18 2005 816 821 (Pubitemid 40780515)
112. K. Inamura, Y. Satoh, and S. Okumura Pulmonary adenocarcinomas with enteric differentiation: histologic and immunohistochemical characteristics compared with metastatic colorectal cancers and usual pulmonary adenocarcinomas Am J Surg Pathol 29 2005 660 665 (Pubitemid 40577877)
113. H. Awaya, Y. Takeshima, M. Yamasaki, and K. Inai Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung Am J Clin Pathol 121 2004 644 653 (Pubitemid 38533996)
114. R.N. Shah, S. Badve, K. Papreddy, S. Schindler, W.B. Laskin, and A.V. Yeldandi Expression of cytokeratin 20 in mucinous bronchioloalveolar carcinoma Hum Pathol 33 2002 915 920
115. R.S. Saad, D.L. Essig, J.F. Silverman, and Y. Liu Diagnostic utility of CDX-2 expression in separating metastatic gastrointestinal adenocarcinoma from other metastatic adenocarcinoma in fine-needle aspiration cytology using cell blocks Cancer 102 2004 168 173 (Pubitemid 38780602)
116. G. Rossi, B. Murer, and A. Cavazza Primary mucinous (so-called colloid) carcinomas of the lung: a clinicopathologic and immunohistochemical study with special reference to CDX-2 homeobox gene and MUC2 expression Am J Surg Pathol 28 2004 442 452 (Pubitemid 38436517)
117. P.G. Chu, L. Chung, L.M. Weiss, and S.K. Lau Determining the site of origin of mucinous adenocarcinoma: an immunohistochemical study of 175 cases Am J Surg Pathol 35 2011 1830 1836
118. C.M. Hobbs, M.A. Lowry, D. Owen, and L.H. Sobin Anal gland carcinoma Cancer 92 2001 2045 2049 (Pubitemid 32973312)
119. J.R. Goldblum, and W.R. Hart Perianal Paget's disease: a histologic and immunohistochemical study of 11 cases with and without associated rectal adenocarcinoma Am J Surg Pathol 22 1998 170 179 (Pubitemid 28113377)
120. Z.M. Chen, and H.L. Wang Alteration of cytokeratin 7 and cytokeratin 20 expression profile is uniquely associated with tumorigenesis of primary adenocarcinoma of the small intestine Am J Surg Pathol 28 2004 1352 1359 (Pubitemid 39336375)
121. Z.M. Chen, J.H. Ritter, and H.L. Wang Differential expression of alpha-methylacyl coenzyme A racemase in adenocarcinomas of the small and large intestines Am J Surg Pathol 29 2005 890 896 (Pubitemid 40885011)
122. M.Q. Zhang, F. Lin, P. Hui, Z.M. Chen, J.H. Ritter, and H.L. Wang Expression of mucins, SIMA, villin, and CDX2 in small-intestinal adenocarcinoma Am J Clin Pathol 128 2007 808 816 (Pubitemid 350133993)
123. M.J. Lee, H.S. Lee, W.H. Kim, Y. Choi, and M. Yang Expression of mucins and cytokeratins in primary carcinomas of the digestive system Mod Pathol 16 2003 403 410 (Pubitemid 36618459)
124. S.A. Geller, D. Dhall, and R. Alsabeh Application of immunohistochemistry to liver and gastrointestinal neoplasms: liver, stomach, colon, and pancreas Arch Pathol Lab Med 132 2008 490 499 (Pubitemid 351328818)
125. N.S. Goldstein, and D. Bassi Cytokeratins 7, 17, and 20 reactivity in pancreatic and ampulla of vater adenocarcinomas. Percentage of positivity and distribution is affected by the cut-point threshold Am J Clin Pathol 115 2001 695 702 (Pubitemid 33051536)
126. J.V. Duval, L. Savas, and B.F. Banner Expression of cytokeratins 7 and 20 in carcinomas of the extrahepatic biliary tract, pancreas, and gallbladder Arch Pathol Lab Med 124 2000 1196 1200 (Pubitemid 30650322)
127. P.G. Chu, R.E. Schwarz, S.K. Lau, Y. Yen, and L.M. Weiss Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2 Am J Surg Pathol 29 2005 359 367 (Pubitemid 40321972)
128. V. Kaimaktchiev, L. Terracciano, and L. Tornillo The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas Mod Pathol 17 2004 1392 1399 (Pubitemid 39472995)
129. S.K. Lau, L.M. Weiss, and P.G. Chu Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites Am J Clin Pathol 122 2004 61 69 (Pubitemid 38849873)
130. N.V. Adsay, K. Merati, and A. Andea The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis Mod Pathol 15 2002 1087 1095
131. T.S. Loy, S.C. Sharp, C.J. Andershock, and S.B. Craig Distribution of CA 19-9 in adenocarcinomas and transitional cell carcinomas. An immunohistochemical study of 527 cases Am J Clin Pathol 99 1993 726 728 (Pubitemid 23181823)
132. O. Kaufmann, T. Deidesheimer, M. Muehlenberg, P. Deicke, and M. Dietel Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sites Histopathology 29 1996 233 240 (Pubitemid 26302731)
133. M.A. Kim, H.S. Lee, H.K. Yang, and W.H. Kim Cytokeratin expression profile in gastric carcinomas Hum Pathol 35 2004 576 581 (Pubitemid 38656942)
134. C.K. Ma, R.J. Zarbo, H.F. Frierson, and M.W. Lee Comparative immunohistochemical study of primary and metastatic carcinomas of the liver Am J Clin Pathol 99 1993 551 557 (Pubitemid 23154095)
135. W.A. Lee Alpha-methylacyl-CoA-racemase expression in adenocarcinoma, dysplasia and non-neoplastic epithelium of the stomach Oncology 71 2006 246 250
136. Q. Liu, M. Teh, K. Ito, N. Shah, Y. Ito, and K.G. Yeoh CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancer Mod Pathol 20 2007 1286 1297 (Pubitemid 350126854)
137. F.P. O'Connell, H.H. Wang, and R.D. Odze Utility of immunohistochemistry in distinguishing primary adenocarcinomas from metastatic breast carcinomas in the gastrointestinal tract Arch Pathol Lab Med 129 2005 338 347 (Pubitemid 40343988)
138. D. Villari, R. Caruso, M. Grosso, E. Vitarelli, M. Righi, and G. Barresi Hep Par 1 in gastric and bowel carcinomas: an immunohistochemical study Pathology 34 2002 423 426 (Pubitemid 35205243)
139. M.M. Tian, A.L. Zhao, Z.W. Li, and J.Y. Li Phenotypic classification of gastric signet ring cell carcinoma and its relationship with clinicopathologic parameters and prognosis World J Gastroenterol 13 2007 3189 3198